Azafaros is a clinical-stage company developing innovative therapies for rare lysosomal storage disorders, including Niemann-Pick disease Type C and GM1/GM2 gangliosidoses.

Perfuze is a medical device company that develops catheters designed to improve stroke treatment by enhancing the trackability and delivery of aspiration catheters.

Coave Therapeutics develops genetic medicines using their ALIGATER™ platform to enhance treatment for CNS, neuromuscular, and eye diseases.

Deciphex is an AI-powered digital pathology company that enhances diagnostic efficiency and accuracy for pathologists.

ShiraTronics develops a neuromodulation device for treating chronic migraine patients.

Shorla Oncology is a pharmaceutical company that develops oncology drugs for orphan and pediatric cancers, with a focus on addressing drug shortages and improving the preparation and application of oncology medication.